Index Ventures Backs XO1
XO1 Ltd, a biotechnology company, said on Monday that it has raised $11 in Series A financing from Index Ventures. According to XO1, the funding will be used to develop an anticoagulant drug. Also, Kevin Johnson, a partner at Index Ventures, will join XO1's board.
17 June 2013•4 mins read
